Lorazepam Export Market Intelligence: India's 24 Suppliers Shipping to 21 Countries — TransData Nexus 2026

Q: Who are the top lorazepam exporters from India?

The top lorazepam exporters from India are: 1. APL HEALTHCARE LIMITED — $947.1K (37.7% market share); 2. CENTAUR PHARMACEUTICALS PRIVATE LIMITED — $471.7K (18.8% market share); 3. VENOR PHARMA LIMITED — $227.2K (9.0% market share); 4. ESJAY PHARMA PRIVATE LIMITED — $200.0K (8.0% market share); 5. J B CHEMICALS AND PHARMACEUTICALS LIMITED — $156.3K (6.2% market share). Together they account for 79.6% of India's total lorazepam export value.

Q: What is the total export value of lorazepam from India?

The total export value of lorazepam from India is $2.5M USD, recorded across 125 shipment transactions from 24 active exporters to 21 destination countries. The average shipment value is $20.1K.

Q: Which countries import lorazepam from India?

India exports lorazepam to 21 countries worldwide. The top importing countries are: UNITED STATES (45.6% share, $1.1M), SRI LANKA (13.4% share, $337.2K), UNITED KINGDOM (13.4% share, $336.0K), FINLAND (11.2% share, $282.4K), SWITZERLAND (5.3% share, $132.8K). These five markets account for 88.9% of total export value.

Q: What is the HS code for lorazepam exports from India?

The primary HS code for lorazepam exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of lorazepam exports from India?

The average unit price for lorazepam exports from India is $2.38 USD per unit, with prices ranging from $0.01 to $48.58 depending on formulation, packaging, and order volume. The total market is valued at $2.5M across 125 shipments.

Q: Which ports handle lorazepam exports from India?

The primary ports for lorazepam exports from India are SAHAR AIR CARGO ACC (INBOM4) (17.6% of shipments), NHAVA SHEVA SEA (INNSA1) (12.8% of shipments), JNPT/ NHAVA SHEVA SEA (10.4% of shipments), CHENNAI AIR CARGO ACC (INMAA4) (8.8% of shipments), APIIC LIMITED -NAIDUPETA SEZ (8.8% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of lorazepam?

India is one of the world's leading exporters of lorazepam due to its large base of 24 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports lorazepam to 21 countries, demonstrating 11% global market coverage.

Q: What certifications do Indian lorazepam exporters need?

Indian lorazepam exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import lorazepam from India?

There are 46 registered buyers importing lorazepam from India, spread across 21 countries. The repeat buyer rate is 50.0%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top lorazepam supplier from India?

APL HEALTHCARE LIMITED is the leading lorazepam exporter from India with a market share of 37.7% and total export value of $947.1K across 19 shipments. The top 5 suppliers together control 79.6% of total export value.

Suresh Sormare

Lorazepam

India Pharmaceutical Trade Intelligence

$2.5M24 Suppliers21 CountriesHS 30049099

ExportsIndia → UNITED STATES45.6%India → SRI LANKA13.4%

ImportsUNITED STATES → India$34.1K GERMANY → India$26.3K

#1 Supplier: APL HEALTHCARE #1 Buyer: XXROBXXDO XXARMXXUSAXX

Lorazepam Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Lorazepam to the World

Between 2022 and 2026, India exported $2.5M worth of lorazepam across 125 verified shipments to 21 countries — covering 11% of world markets in the CNS & Psychiatric segment. The largest destination is UNITED STATES (45.6%). APL HEALTHCARE LIMITED leads with a 37.7% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·HS 30049099

Lorazepam export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Lorazepam export data snapshot — $2.5M · 24 exporters · 21 countriesTransData Nexus · Indian Customs Data

Top Lorazepam Exporters from India

24 active exporters · Ranked by export value

View all 24 →

Top Lorazepam Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	APL HEALTHCARE LIMITED	$947.1K	19	1	37.7%
2	CENTAUR PHARMACEUTICALS PRIVATE LIMITED

Top Countries Importing Lorazepam from India

21 destination markets · Ranked by import value

All 21 countries →

Top Countries Importing Lorazepam from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$1.1M	45.6%
2	SRI LANKA	$337.2K	13.4%
3	UNITED KINGDOM	$336.0K	13.4%
4	FINLAND	$282.4K	11.2%
5	SWITZERLAND	$132.8K	5.3%
6	MYANMAR	$82.0K	3.3%
7	GERMANY	$79.9K	3.2%
8	NICARAGUA	$42.3K	1.7%
9	SOMALIA	$20.2K	0.8%
10	KENYA	$15.5K	0.6%

UNITED STATES is India's largest lorazepam export destination, absorbing 45.6% of total exports worth $1.1M. The top 5 importing countries — UNITED STATES, SRI LANKA, UNITED KINGDOM, FINLAND, SWITZERLAND — together account for 88.9% of India's total lorazepam export value. The remaining 16 destination countries collectively receive the other 11.1%, indicating a focused distribution strategy targeting key markets.

Who Supplies Lorazepam to India?

4 origin countries · Total import value: $61.2K

India imports lorazepam from 4 countries with a combined import value of $61.2K. The largest supplier is UNITED STATES ($34.1K, 8 shipments), followed by GERMANY and CANADA. All values are from Indian Customs (DGFT) import records.

Countries Supplying Lorazepam to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	UNITED STATES	$34.1K	8	55.7%
2	GERMANY	$26.3K	9	43.0%
3	CANADA	$453	4	0.7%
4	UNITED KINGDOM	$300	1	0.5%

UNITED STATES is the largest supplier of lorazepam to India, accounting for 55.7% of total import value. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Lorazepam

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

Lorazepam, a benzodiazepine used primarily for anxiety disorders, has been available in the U.S. market for several decades. The FDA approved the first generic versions of lorazepam in the late 1990s. For instance, Elkins-Sinn received approval for their generic lorazepam on September 28, 1998, and Mova Pharmaceutical Corporation's lorazepam injection was approved on March 16, 2000.

The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for lorazepam, indicating a competitive generic market. As of March 2026, there are no active import alerts or significant regulatory actions against lorazepam products from India. This regulatory stability aligns with our data, which shows that 24 Indian exporters have successfully shipped lorazepam to the U.S., accounting for 45.6% of the total export value.

2EU & UK Regulatory Framework

In the European Union, lorazepam is subject to stringent regulatory oversight. The European Medicines Agency (EMA) has evaluated lorazepam-containing products, such as Lorazepam Macure. In June 2024, the EMA's Committee for Medicinal Products for Human Use (CHMP) recommended updating the product information to include the control of status epilepticus in various age groups. However, they also highlighted potential risks associated with excipients in young children (ema.europa.eu).

The United Kingdom's Medicines and Healthcare products Regulatory Agency (MHRA) continues to align with EMA guidelines post-Brexit, ensuring that lorazepam products meet EU Good Manufacturing Practice (GMP) standards. Our data indicates that the UK is a significant importer, accounting for 13.4% of India's lorazepam exports.

3WHO Essential Medicines & Global Standards

Lorazepam is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its importance in global healthcare. The drug is recognized in major pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring standardized quality across different markets.

4India Regulatory Classification

In India, lorazepam is classified under Schedule H of the Drugs and Cosmetics Act, requiring a prescription for dispensing. The National Pharmaceutical Pricing Authority (NPPA) has not imposed a ceiling price on lorazepam, allowing market-driven pricing. For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC) for controlled substances, ensuring compliance with international regulations.

5Patent & Exclusivity Status

The primary patents for lorazepam have long expired, leading to a robust generic market. This has facilitated the entry of multiple Indian manufacturers into the global market, as evidenced by our data showing 24 active exporters.

6Recent Industry Developments

In June 2024, the EMA recommended updating the product information for Lorazepam Macure to include the treatment of status epilepticus and highlighted potential risks associated with certain excipients in young children (ema.europa.eu).

In August 2024, the European Commission issued a legally binding decision to implement these changes across EU member states (ema.europa.eu).

In January 2025, the NPPA conducted a review of benzodiazepine pricing, including lorazepam, but decided against imposing a ceiling price, maintaining a market-driven approach.

In March 2025, the FDA approved a new generic version of lorazepam oral concentrate, further increasing competition in the U.S. market.

In October 2025, the WHO updated its Model List of Essential Medicines, reaffirming the inclusion of lorazepam for the management of anxiety and seizure disorders.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Lorazepam

Retail & reference prices across 9 markets vs. India FOB export price of $2.38/unit

Global Price Benchmark for Lorazepam across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.45	USD	According to the FDA's National Drug Code Directory, the average pharmacy acquisition cost for lorazepam 0.5 mg tablets is approximately $0.038 per unit as of January 2026.
United Kingdom	$0.13	GBP	As per the NHS Drug Tariff, the reimbursement price for lorazepam 0.5 mg tablets is £0.10 per unit as of March 2026.
Germany	$0.13	EUR	According to the German Federal Institute for Drugs and Medical Devices (BfArM), the reference price for lorazepam 0.5 mg tablets is €0.12 per unit as of March 2026.
Australia

Supply Chain Risk Assessment — Lorazepam

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

Lorazepam, a benzodiazepine used for anxiety and seizure disorders, is primarily manufactured in India. However, the production of its Active Pharmaceutical Ingredient (API) heavily relies on Key Starting Materials (KSMs) sourced from China. This dependency is part of a broader trend where China controls approximately 70–80% of the global KSM supply and 60–70% of the global intermediate supply, making it a dominant player in the pharmaceutical raw material market.

Recent geopolitical tensions have exacerbated this vulnerability. In February 2026, the closure of the Strait of Hormuz disrupted the supply of naphtha, a critical feedstock for chemical production, affecting Asian chemical manufacturers. Facilities that rely on Middle Eastern naphtha began experiencing procurement delays, leading to force majeure declarations and production cutbacks. Such disruptions highlight the fragility of supply chains dependent on specific regions for essential raw materials.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five Indian exporters of Lorazepam account for 79.6% of total exports, with APL Healthcare Limited alone contributing 37.7%. This high supplier concentration poses a significant risk; any operational or compliance issues within these key companies could disrupt the global supply of Lorazepam.

Access Complete Lorazepam Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 125 transactions across 21 markets.

Request Demo View Pricing

Frequently Asked Questions — Lorazepam Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top lorazepam exporters from India?

The leading lorazepam exporters from India are APL HEALTHCARE LIMITED, CENTAUR PHARMACEUTICALS PRIVATE LIMITED, VENOR PHARMA LIMITED, and 6 others. APL HEALTHCARE LIMITED leads with 37.7% market share ($947.1K). The top 5 suppliers together control 79.6% of total export value.

What is the total export value of lorazepam from India?

The total export value of lorazepam from India is $2.5M, recorded across 125 shipments from 24 active exporters to 21 countries. The average shipment value is $20.1K.

Which countries import lorazepam from India?

India exports lorazepam to 21 countries. The top importing countries are UNITED STATES (45.6%), SRI LANKA (13.4%), UNITED KINGDOM (13.4%), FINLAND (11.2%), SWITZERLAND (5.3%), which together account for 88.9% of total export value.

What is the HS code for lorazepam exports from India?

The primary HS code for lorazepam exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Lorazepam

Lorazepam

Top Lorazepam Exporters from India

Top Countries Importing Lorazepam from India

Who Supplies Lorazepam to India?

Quick Facts

Related CNS & Psychiatric

Related Analysis

Need Details?

Regulatory Landscape — Lorazepam

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Lorazepam

Supply Chain Risk Assessment — Lorazepam

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Lorazepam Trade Intelligence

Frequently Asked Questions — Lorazepam Exports from India

Who are the top lorazepam exporters from India?

What is the total export value of lorazepam from India?

Which countries import lorazepam from India?

What is the HS code for lorazepam exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of lorazepam exports from India?

Which ports handle lorazepam exports from India?

Why is India a leading exporter of lorazepam?

What certifications do Indian lorazepam exporters need?

How many buyers import lorazepam from India?

What is the market share of the top lorazepam exporter from India?

Analysis Methodology